Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Organon & Co. Common Stock
(NY:
OGN
)
6.355
+0.025 (+0.39%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,089,735
Open
6.340
Bid (Size)
6.350 (19,500)
Ask (Size)
6.360 (6,600)
Prev. Close
6.330
Today's Range
6.320 - 6.478
52wk Range
6.180 - 15.88
Shares Outstanding
259,965,579
Dividend Yield
1.26%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 of Wall Street’s Favorite Stocks We Approach with Caution
Today 0:46 EDT
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via
StockStory
3 Small-Cap Stocks We Approach with Caution
March 04, 2026
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Via
StockStory
Performance
YTD
-12.2%
-12.2%
1 Month
-18.6%
-18.6%
3 Month
-13.7%
-13.7%
6 Month
-40.4%
-40.4%
1 Year
-57.6%
-57.6%
More News
Read More
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis
February 27, 2026
From
Organon & Co.
Via
Business Wire
Organon & Co (NYSE:OGN) Shares Drop on Q4 Earnings Miss and Flat 2026 Outlook
↗
February 12, 2026
Via
Chartmill
Topics
Earnings
The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy
February 26, 2026
Via
Finterra
Topics
Economy
Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
February 23, 2026
From
Organon & Co.
Via
Business Wire
5 Revealing Analyst Questions From Organon’s Q4 Earnings Call
February 19, 2026
Via
StockStory
Topics
Earnings
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know
February 13, 2026
Via
StockStory
Topics
Economy
OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook
February 13, 2026
Via
StockStory
Organon (OGN) Q4 2025 Earnings Call Transcript
↗
February 12, 2026
Via
The Motley Fool
Topics
Earnings
Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations
February 12, 2026
Via
StockStory
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025
February 12, 2026
From
Organon & Co.
Via
Business Wire
Organon Earnings: What To Look For From OGN
February 10, 2026
Via
StockStory
Topics
Artificial Intelligence
World Trade
2 Healthcare Stocks with Promising Prospects and 1 We Brush Off
February 04, 2026
Via
StockStory
Topics
Stocks
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026
January 29, 2026
From
Organon & Co.
Via
Business Wire
Organon Completes Divestiture of JADA® System to Laborie
January 28, 2026
From
Organon & Co.
Via
Business Wire
The Post-Keytruda Pivot: Inside Merck’s Strategic Evolution and the RVMD Landscape
January 26, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
Nasdaq, S&P 500 Futures Rise As Trump Diffuses Tariff Risk: Why INTC, MSFT, NFLX, RKLB, OGN Are On Traders' Radar Today
↗
January 22, 2026
Via
Stocktwits
Topics
ETFs
Earnings
Economy
Why Are Organon (OGN) Shares Soaring Today
January 20, 2026
Via
StockStory
Topics
Artificial Intelligence
Initial Public Offering
Supply Chain
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque
January 16, 2026
From
Organon & Co.
Via
Business Wire
3 Small-Cap Stocks We Approach with Caution
January 07, 2026
Via
StockStory
3 Healthcare Stocks with Questionable Fundamentals
December 15, 2025
Via
StockStory
Topics
Stocks
Why Organon (OGN) Shares Are Trading Lower Today
December 09, 2025
Via
StockStory
Topics
Initial Public Offering
3 Stocks Under $10 We Steer Clear Of
December 08, 2025
Via
StockStory
Frequently Asked Questions
Is Organon & Co. Common Stock publicly traded?
Yes, Organon & Co. Common Stock is publicly traded.
What exchange does Organon & Co. Common Stock trade on?
Organon & Co. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Organon & Co. Common Stock?
The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange
What is the current price of Organon & Co. Common Stock?
The current price of Organon & Co. Common Stock is 6.355
When was Organon & Co. Common Stock last traded?
The last trade of Organon & Co. Common Stock was at 03/13/26 03:58 PM ET
What is the market capitalization of Organon & Co. Common Stock?
The market capitalization of Organon & Co. Common Stock is 1.65B
How many shares of Organon & Co. Common Stock are outstanding?
Organon & Co. Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.